$343 Million is the total value of Sio Capital Management, LLC's 78 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 200.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CHRS | Buy | COHERUS BIOSCIENCES INC | $20,287,000 | +16.0% | 1,135,863 | +5.4% | 5.92% | +1.0% |
| GLD | Buy | SPDR GOLD SHARES | $20,202,000 | +110.9% | 120,702 | +86.6% | 5.90% | +83.6% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDUSTRIES LTDsponsored ads | $11,871,000 | +130.8% | 962,796 | +68.1% | 3.46% | +100.9% |
| ABC | Buy | AMERISOURCEBERGEN CORP | $10,132,000 | +618.6% | 100,545 | +531.2% | 2.96% | +525.2% |
| MOH | Buy | MOLINA HEALTHCARE INC | $10,111,000 | +101.2% | 56,807 | +57.9% | 2.95% | +75.2% |
| HRC | New | HILL-ROM HOLDINGS INC | $9,880,000 | – | 90,000 | +100.0% | 2.88% | – |
| MRK | Buy | MERCK & CO INC | $8,843,000 | +23.5% | 114,350 | +22.8% | 2.58% | +7.5% |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $8,700,000 | +797.8% | 371,781 | +123.6% | 2.54% | +681.2% |
| RCM | New | R1 RCM INC | $8,508,000 | – | 763,023 | +100.0% | 2.48% | – |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $8,027,000 | +3995.4% | 2,299,982 | +1636.2% | 2.34% | +3448.5% |
| SOLY | New | SOLITON INC | $7,975,000 | – | 1,025,000 | +100.0% | 2.33% | – |
| HCA | Buy | HCA HEALTHCARE INC | $7,933,000 | +13.3% | 81,732 | +4.9% | 2.32% | -1.4% |
| LLY | New | ELI LILLY AND CO | $7,536,000 | – | 45,901 | +100.0% | 2.20% | – |
| MESO | Buy | MESOBLAST LTDput | $7,303,000 | +20765.7% | 641,200 | +7816.0% | 2.13% | +17658.3% |
| CAH | New | CARDINAL HEALTH INC | $6,967,000 | – | 133,500 | +100.0% | 2.03% | – |
| OFIX | New | ORTHOFIX MEDICAL INC | $6,141,000 | – | 191,891 | +100.0% | 1.79% | – |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $5,990,000 | +67.5% | 95,153 | +11.7% | 1.75% | +45.9% |
| OSUR | New | ORASURE TECHNOLOGIES INC | $5,350,000 | – | 460,000 | +100.0% | 1.56% | – |
| WBA | New | WALGREENS BOOTS ALLIANCE INC | $5,265,000 | – | 124,194 | +100.0% | 1.54% | – |
| CRIS | New | CURIS INC | $5,203,000 | – | 4,300,051 | +100.0% | 1.52% | – |
| CHAQU | New | CHARDAN HEALTHCARE ACQUISITION 2 CORP | $4,200,000 | – | 400,000 | +100.0% | 1.23% | – |
| LRMR | New | LARIMAR THERAPEUTICS INC | $4,090,000 | – | 318,258 | +100.0% | 1.19% | – |
| IMVT | Buy | IMMUNOVANT INC | $3,712,000 | +109.0% | 152,450 | +33.6% | 1.08% | +82.0% |
| BIIB | New | BIOGEN INCput | $3,692,000 | – | 13,800 | +100.0% | 1.08% | – |
| LPTX | Buy | LEAP THERAPEUTICS INC | $3,139,000 | +80.7% | 1,501,998 | +36.6% | 0.92% | +57.4% |
| VAPO | New | VAPOTHERM INC | $3,113,000 | – | 75,953 | +100.0% | 0.91% | – |
| VRAY | New | VIEWRAY INC | $2,900,000 | – | 1,294,790 | +100.0% | 0.85% | – |
| ATNM | New | ACTINIUM PHARMACEUTICALS INC | $2,864,000 | – | 8,147,650 | +100.0% | 0.84% | – |
| ASLN | Buy | ASLAN PHARMACEUTICALS LTDads | $2,754,000 | +108.5% | 1,376,954 | +6.3% | 0.80% | +81.5% |
| CERC | New | CERECOR INC | $2,600,000 | – | 1,000,000 | +100.0% | 0.76% | – |
| RDNT | New | RADNET INC | $2,146,000 | – | 135,254 | +100.0% | 0.63% | – |
| ZYNE | New | ZYNERBA PHARMACEUTICALS INCput | $2,120,000 | – | 629,000 | +100.0% | 0.62% | – |
| AGLE | New | AEGLEA BIO THERAPEUTICS INC | $1,953,000 | – | 211,104 | +100.0% | 0.57% | – |
| INGN | New | INOGEN INC | $1,918,000 | – | 54,000 | +100.0% | 0.56% | – |
| DYAI | Buy | DYADIC INTERNATIONAL INC | $1,810,000 | +93.6% | 209,064 | +16.3% | 0.53% | +68.7% |
| NBSE | New | NEUBASE THERAPEUTICS INC | $1,575,000 | – | 179,404 | +100.0% | 0.46% | – |
| DTIL | New | PRECISION BIOSCIENCES INC | $1,541,000 | – | 185,053 | +100.0% | 0.45% | – |
| ANIK | New | ANIKA THERAPEUTICS INC | $1,359,000 | – | 36,032 | +100.0% | 0.40% | – |
| AYLA | New | AYALA PHARMACEUTICALS INC | $1,157,000 | – | 114,546 | +100.0% | 0.34% | – |
| STRO | New | SUTRO BIOPHARMA INC | $1,152,000 | – | 148,400 | +100.0% | 0.34% | – |
| KOD | Buy | KODIAK SCIENCES INC | $1,115,000 | +55.7% | 20,595 | +37.3% | 0.32% | +35.4% |
| NERV | New | MINERVA NEUROSCIENCES INCput | $878,000 | – | 243,300 | +100.0% | 0.26% | – |
| BNGO | New | BIONANO GENOMICS INC | $789,000 | – | 1,546,184 | +100.0% | 0.23% | – |
| IDYA | New | IDEAYA BIOSCIENCES INC | $782,000 | – | 55,000 | +100.0% | 0.23% | – |
| KURA | New | KURA ONCOLOGY INC | $696,000 | – | 42,683 | +100.0% | 0.20% | – |
| MCRB | New | SERES THERAPEUTICS INCput | $264,000 | – | 55,500 | +100.0% | 0.08% | – |
| CLRB | New | CELLECTAR BIOSCIENCES INC | $243,000 | – | 189,457 | +100.0% | 0.07% | – |
| FUSN | New | FUSION PHARMACEUTICALS INC | $52,000 | – | 3,000 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.